{
  "created_at": "2019-12-24T03:37:33.000Z",
  "updated_at": "2021-01-06T08:24:48.644Z",
  "id": "2b635bb3-d2d1-4762-88cc-06d63a164b08",
  "labels": "current-affairs,2019-12-25",
  "question": "With regards to the recently approved Ontruzant medicine, consider the following statements:<br />\r\n<ol>\r\n<li>It is used for treatment of cancer.</li>\r\n<li>It is a biosimilar compoud.</li>\r\n</ol>\r\nSelect the correct option from the codes given below:",
  "option1": "Only 1 is correct",
  "option2": "Only 2 is correct",
  "option3": "Neither 1 nor 2 is correct",
  "option4": "Both 1 and 2 are correct",
  "option5": "",
  "answer": "Both 1 and 2 are correct",
  "explanation": "<strong>Statement 1 is correct:</strong>\r\nThe compound Ontruzant is used to treat breast cancer. It was recently approved for use by the World Health Organisation. It is to be used instead of the more expensive version, Trastuzumab. The Ontruzant medicine is to be supplied by Samsung Bioepis Co Ltd.\r\n<strong>Statement 2 is correct:        </strong>\r\nThe compound Ontruzant is a ‘biosimilar’ of Trastuzumab. Biosimilars are compounds that are derived from biological sources. These behave in a manner similar to previously licensed drugs. This is the first such biosimilar of Trastuzumab approved by the international health body."
}